Patents Assigned to Clear Lake Development Group
  • Patent number: 4529583
    Abstract: A therapeutic composition is coated with a mixture of an emetic chemical and an inert material. A method for reducing absorption into the body of a being of an emetic chemical while still retaining localized emetic activity comprises combining prior to ingestion of the chemical, the emetic chemical with a material that is substantially inert to a gastrointestinal environment such that when the combination is ingested and passed along the gastrointestinal tract, localized emetic activity is available while an undesirable amount of the emetic chemical is not absorbed into the body. A method of inducing emesis in the body of a being to preclude death from accidental or intentional overdosage of a therapeutic composition, which is normally of the type which if ingested by prescription is safe, but if excessively ingested is lethal while simultaneously reducing absorption of an emetic chemical into the body.
    Type: Grant
    Filed: April 12, 1984
    Date of Patent: July 16, 1985
    Assignee: Clear Lake Development Group
    Inventors: Garry L. Porter, Ram P. Singhal
  • Patent number: 4459278
    Abstract: A therapeutic composition is coated with a mixture of an emetic chemical and an inert material. A method for reducing absorption into the body of a being of an emetic chemical while still retaining localized emetic activity comprises combining prior to ingestion of the chemical, the emetic chemical with a material that is substantially inert to a gastrointestinal environment such that when the combination is ingested and passed along the gastrointestinal tract, localized emetic activity is available while an undesirable amount of the emetic chemical is not absorbed into the body. A method of inducing emesis in the body of a being to preclude death from accidental or intentional overdosage of a therapeutic composition, which is normally of the type which if ingested by prescription is safe, but if excessively ingested is lethal while simultaneously reducing absorption of an emetic chemical into the body.
    Type: Grant
    Filed: March 7, 1983
    Date of Patent: July 10, 1984
    Assignee: Clear Lake Development Group
    Inventor: Garry L. Porter
  • Patent number: 4457907
    Abstract: A therapeutic composition comprising a therapeutic drug that can cause undesirable effects on the pre-intestinal phases when contacting these phases, and an enteric coating surrounding the drug. A method for protecting a therapeutic drug including forming an enteric coating around the drug.
    Type: Grant
    Filed: August 5, 1982
    Date of Patent: July 3, 1984
    Assignee: Clear Lake Development Group
    Inventor: Garry L. Porter